Comments
Loading...

Intra-Cellular Therapies

ITCINASDAQ
Logo brought to you by Benzinga Data
$74.70
-0.41-0.55%
At Close: -
$74.70
00.00%
After Hours: 4:38 PM EDT
15 minutes delayed

Intra-Cellular Therapies (NASDAQ:ITCI) Stock, Earnings Estimates, EPS, And Revenue

Intra-Cellular Therapies reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Oct 31
EPS Estimate
$-0.190
Quarterly Revenue Estimate
$172.2M
Annual Revenue
(as of Jun 30)
$563.4M

Analyze the earnings history of Intra-Cellular Therapies using advanced sorting and filters.

Data brought to you by Benzinga APIs

Intra-Cellular Therapies (ITCI) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Jun 20242024-08-07$-0.16$-0.1915.8 %
Mar 20242024-05-07$-0.16$-0.3351.5 %
Dec 20232024-02-22$-0.30$-0.4330.2 %
Sep 20232023-11-02$-0.25$-0.5655.4 %

Intra-Cellular Therapies (ITCI) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %
Jun 20242024-08-07$161.39M$157.88M2.22 %
Mar 20242024-05-07$144.87M$140.91M2.81 %
Dec 20232024-02-22$132.10M$136.79M-3.43 %
Sep 20232023-11-02$126.17M$119.35M5.72 %

FAQ

Q

When is Intra-Cellular Therapies (NASDAQ:ITCI) reporting earnings?

A

Intra-Cellular Therapies (ITCI) is scheduled to report earnings on October 31, 2024. The last reported earnings were for reported on August 7, 2024 for Q2.

Q

What were the latest earnings per share (EPS) for Intra-Cellular Therapies (NASDAQ:ITCI)?

A

The Actual EPS was $-0.16, which beat the estimate of $-0.19.

Q

What were Intra-Cellular Therapies’s (NASDAQ:ITCI) revenues?

A

The Actual Revenue was $161.4M, which beat the estimate of $157.9M.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch